Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep;70(5):644-7.
doi: 10.4103/0250-474X.45406.

Stability Indicating HPTLC Determination of Meloxicam

Affiliations

Stability Indicating HPTLC Determination of Meloxicam

Namita Desai et al. Indian J Pharm Sci. 2008 Sep.

Abstract

A simple, selective, precise and stability-indicating high-performance thin layer chromatographic method of analysis of meloxicam both as a bulk drug and in formulation has been developed. The mobile phase selected was ethyl acetate:cyclohexane:glacial acetic acid (6.5:3.5:0.02% v/v/v). The calibration curve of the drug was linear in the range of 100-500 ng. The spectrodensitometric analysis was carried out in the absorbance mode at 353 nm. The mean (±RSD) values of slope, correlation coefficient and intercept were 3183.8±0.358, 0.9996±0.0321 and 13012±7.1 respectively. The system precision and the method precision studies were carried out with RSD of 0.83 and 1.89 respectively. The limit of detection and quantitation were 30 ng and 99 ng respectively. The mean percent recovery was found to be 100.3%. The method was used to analyze meloxicam from marketed tablet formulation in the presence of commonly used excipients.

Keywords: HPTLC; Meloxicam; antiinflammatory; stability indicating.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Separation of degradates of Meloxicam by HPTLC A= meloxicam standard, B= acid degradation, C= base degradation, D= heat degradation, E= photodegradation, F= oxidative degradation, G= placebo

References

    1. Noble S, Balfour JA. Meloxicam. Drugs. 1996;51:424–33. - PubMed
    1. Krishnan PV, editor. Meloxicam in: Current index of medical specialties. Bangalore: Bio Gard Pvt Ltd; 2000. p. 53.
    1. Degner F, Turck Di, Pairet M. Pharmacological, pharmacokinetic and clinical profile of meloxicam. Drugs Today. 1997;33:739–58.
    1. Radi MA, El Ries F, El-Anwar Z, El-Sherif Electrochemical oxidation of meloxicam and its determination in tablet dosage form. Anal Lett. 2001;34:739–48.
    1. Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and β-cyclodextrin. AAPS Pharm Sci Tech Online. 2004;5:59. - PMC - PubMed

LinkOut - more resources